Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite™) improves symptoms and diagnostic indicators in rheumatoid arthritis patients - A randomized, double blind and placebo controlled study.

Jacob J, Amalraj A, Raj KKJ, Divya C, Kunnumakkara AB, Gopi S.

J Tradit Complement Med. 2018 Oct 10;9(4):346-352. doi: 10.1016/j.jtcme.2018.06.001. eCollection 2019 Oct.

2.

An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, Padmavathi G, Shakibaei M, Fan L, Sethi G, Kunnumakkara AB.

Int J Mol Sci. 2019 Aug 22;20(17). pii: E4101. doi: 10.3390/ijms20174101. Review.

3.

Is curcumin bioavailability a problem in humans: lessons from clinical trials.

Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, Gupta SC, Aggarwal BB.

Expert Opin Drug Metab Toxicol. 2019 Aug 29:1-29. doi: 10.1080/17425255.2019.1650914. [Epub ahead of print]

PMID:
31361978
4.

Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.

Roy NK, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar NS, Singh AK, Bordoloi D, Baruah MN, Ahmed GN, Longkumar I, Arfuso F, Kumar AP, Kunnumakkara AB.

Biomolecules. 2019 Jun 27;9(7). pii: E253. doi: 10.3390/biom9070253.

5.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Review.

PMID:
31002949
6.

Cancer drug development: The missing links.

Kunnumakkara AB, Bordoloi D, Sailo BL, Roy NK, Thakur KK, Banik K, Shakibaei M, Gupta SC, Aggarwal BB.

Exp Biol Med (Maywood). 2019 May;244(8):663-689. doi: 10.1177/1535370219839163. Epub 2019 Apr 8.

PMID:
30961357
7.

Microwave-assisted synthesis of cellulose/zinc-sulfate‑calcium-phosphate (ZSCAP) nanocomposites for biomedical applications.

Dharmalingam K, Padmavathi G, Kunnumakkara AB, Anandalakshmi R.

Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:535-543. doi: 10.1016/j.msec.2019.02.109. Epub 2019 Mar 12.

PMID:
30948090
8.

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.

Buhrmann C, Yazdi M, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M.

Nutrients. 2019 Mar 26;11(3). pii: E704. doi: 10.3390/nu11030704.

9.

FBXW7 in Cancer: What Has Been Unraveled Thus Far?

Sailo BL, Banik K, Girisa S, Bordoloi D, Fan L, Halim CE, Wang H, Kumar AP, Zheng D, Mao X, Sethi G, Kunnumakkara AB.

Cancers (Basel). 2019 Feb 19;11(2). pii: E246. doi: 10.3390/cancers11020246. Review.

10.

Potential of Zerumbone as an Anti-Cancer Agent.

Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB.

Molecules. 2019 Feb 18;24(4). pii: E734. doi: 10.3390/molecules24040734. Review.

11.

Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations.

Nair A, Amalraj A, Jacob J, Kunnumakkara AB, Gopi S.

Biomolecules. 2019 Jan 2;9(1). pii: E13. doi: 10.3390/biom9010013. Review.

12.

Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer.

Banerjee K, Padmavathi G, Bhattacherjee D, Saha S, Kunnumakkara AB, Bhabak KP.

Org Biomol Chem. 2018 Nov 21;16(45):8769-8782. doi: 10.1039/c8ob01891j.

PMID:
30403243
13.

Nature-inspired development of unnatural meroterpenoids as the non-toxic anti-colon cancer agents.

Haque MA, Sailo BL, Padmavathi G, Kunnumakkara AB, Jana CK.

Eur J Med Chem. 2018 Dec 5;160:256-265. doi: 10.1016/j.ejmech.2018.08.088. Epub 2018 Aug 30.

PMID:
30368201
14.

Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.

Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB.

Front Immunol. 2018 Sep 27;9:2160. doi: 10.3389/fimmu.2018.02160. eCollection 2018. Review.

15.

In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.

Maruthanila VL, Elancheran R, Roy NK, Bhattacharya A, Kunnumakkara AB, Kabilan S, Kotoky J.

Curr Comput Aided Drug Des. 2019;15(1):89-96. doi: 10.2174/1573409914666181008165356.

PMID:
30306879
16.

TIPE Family of Proteins and Its Implications in Different Chronic Diseases.

Bordoloi D, Banik K, Shabnam B, Padmavathi G, Monisha J, Arfuso F, Dharmarajan A, Mao X, Lim LHK, Wang L, Fan L, Hui KM, Kumar AP, Sethi G, Kunnumakkara AB.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2974. doi: 10.3390/ijms19102974. Review.

18.

Sorcin a Potential Molecular Target for Cancer Therapy.

Shabnam B, Padmavathi G, Banik K, Girisa S, Monisha J, Sethi G, Fan L, Wang L, Mao X, Kunnumakkara AB.

Transl Oncol. 2018 Dec;11(6):1379-1389. doi: 10.1016/j.tranon.2018.08.015. Epub 2018 Sep 11. Review.

19.

Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Kunnumakkara AB, Banik K, Bordoloi D, Harsha C, Sailo BL, Padmavathi G, Roy NK, Gupta SC, Aggarwal BB.

Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Review.

20.

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.

Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, Fan L, Kumar AP, Kunnumakkara AB.

Int J Mol Sci. 2018 Aug 10;19(8). pii: E2362. doi: 10.3390/ijms19082362. Review.

21.

NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance.

Monisha J, Roy NK, Padmavathi G, Banik K, Bordoloi D, Khwairakpam AD, Arfuso F, Chinnathambi A, Alahmadi TA, Alharbi SA, Sethi G, Kumar AP, Kunnumakkara AB.

Cancers (Basel). 2018 Jul 10;10(7). pii: E228. doi: 10.3390/cancers10070228.

22.

Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression.

Padmavathi G, Banik K, Monisha J, Bordoloi D, Shabnam B, Arfuso F, Sethi G, Fan L, Kunnumakkara AB.

Cancer Lett. 2018 Sep 28;432:260-271. doi: 10.1016/j.canlet.2018.06.017. Epub 2018 Jun 18. Review.

PMID:
29920292
23.

Possible use of Punica granatum (Pomegranate) in cancer therapy.

Khwairakpam AD, Bordoloi D, Thakur KK, Monisha J, Arfuso F, Sethi G, Mishra S, Kumar AP, Kunnumakkara AB.

Pharmacol Res. 2018 Jul;133:53-64. doi: 10.1016/j.phrs.2018.04.021. Epub 2018 May 2. Review.

PMID:
29729421
24.

Novel AKT1 mutations associated with cell-cycle abnormalities in gastric carcinoma.

Ghatak S, Lalnunhlimi S, Lalrohlui F, Pautu JL, Zohmingthanga J, Kunnumakkara AB, Kumar NS.

Per Med. 2018 Mar;15(2):79-86. doi: 10.2217/pme-2017-0053. Epub 2018 Jan 30.

PMID:
29714127
25.

Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.

Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB.

Pharmacol Res. 2018 Apr;130:259-272. doi: 10.1016/j.phrs.2018.02.017. Epub 2018 Feb 27. Review.

PMID:
29496592
26.

Targeting IκappaB kinases for cancer therapy.

Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC.

Semin Cancer Biol. 2019 Jun;56:12-24. doi: 10.1016/j.semcancer.2018.02.007. Epub 2018 Feb 24. Review.

PMID:
29486318
27.

Acorus calamus: a bio-reserve of medicinal values.

Khwairakpam AD, Damayenti YD, Deka A, Monisha J, Roy NK, Padmavathi G, Kunnumakkara AB.

J Basic Clin Physiol Pharmacol. 2018 Mar 28;29(2):107-122. doi: 10.1515/jbcpp-2016-0132. Review.

PMID:
29389665
28.

Chronic diseases, inflammation, and spices: how are they linked?

Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB.

J Transl Med. 2018 Jan 25;16(1):14. doi: 10.1186/s12967-018-1381-2. Review.

29.

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer.

Banik K, Harsha C, Bordoloi D, Lalduhsaki Sailo B, Sethi G, Leong HC, Arfuso F, Mishra S, Wang L, Kumar AP, Kunnumakkara AB.

Cancer Lett. 2018 Mar 1;416:75-86. doi: 10.1016/j.canlet.2017.12.014. Epub 2017 Dec 13. Review.

PMID:
29246645
30.

Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study.

Gopi S, Jacob J, Varma K, Jude S, Amalraj A, Arundhathy CA, George R, Sreeraj TR, Divya C, Kunnumakkara AB, Stohs SJ.

Phytother Res. 2017 Dec;31(12):1883-1891. doi: 10.1002/ptr.5931. Epub 2017 Oct 13.

PMID:
29027274
31.

Neem (Azadirachta indica): An indian traditional panacea with modern molecular basis.

Gupta SC, Prasad S, Tyagi AK, Kunnumakkara AB, Aggarwal BB.

Phytomedicine. 2017 Oct 15;34:14-20. doi: 10.1016/j.phymed.2017.07.001. Epub 2017 Jul 3. Review.

PMID:
28899496
32.

A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.

Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ, Gopi S.

J Med Food. 2017 Oct;20(10):1022-1030. doi: 10.1089/jmf.2017.3930. Epub 2017 Aug 29.

PMID:
28850308
33.

Alarming Burden of Triple-Negative Breast Cancer in India.

Thakur KK, Bordoloi D, Kunnumakkara AB.

Clin Breast Cancer. 2018 Jun;18(3):e393-e399. doi: 10.1016/j.clbc.2017.07.013. Epub 2017 Jul 20. Review.

PMID:
28801156
34.

Antiulcer properties of fruits and vegetables: A mechanism based perspective.

Harsha C, Banik K, Bordoloi D, Kunnumakkara AB.

Food Chem Toxicol. 2017 Oct;108(Pt A):104-119. doi: 10.1016/j.fct.2017.07.023. Epub 2017 Jul 12. Review.

PMID:
28711545
35.

Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.

Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB.

Clin Sci (Lond). 2017 Jul 5;131(15):1781-1799. doi: 10.1042/CS20160935. Print 2017 Aug 1. Review.

PMID:
28679846
36.

Butein in health and disease: A comprehensive review.

Padmavathi G, Roy NK, Bordoloi D, Arfuso F, Mishra S, Sethi G, Bishayee A, Kunnumakkara AB.

Phytomedicine. 2017 Feb 15;25:118-127. doi: 10.1016/j.phymed.2016.12.002. Epub 2016 Dec 12. Review.

PMID:
28190465
37.

Therapeutic implications of toll-like receptors in peripheral neuropathic pain.

Thakur KK, Saini J, Mahajan K, Singh D, Jayswal DP, Mishra S, Bishayee A, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2017 Jan;115:224-232. doi: 10.1016/j.phrs.2016.11.019. Epub 2016 Nov 25. Review.

PMID:
27894923
38.

Recent development of targeted approaches for the treatment of breast cancer.

Maruthanila VL, Elancheran R, Kunnumakkara AB, Kabilan S, Kotoky J.

Breast Cancer. 2017 Mar;24(2):191-219. doi: 10.1007/s12282-016-0732-1. Epub 2016 Oct 31. Review.

PMID:
27796923
39.

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB.

Br J Pharmacol. 2017 Jun;174(11):1325-1348. doi: 10.1111/bph.13621. Epub 2016 Oct 21. Review.

40.

NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization.

Monisha J, Padmavathi G, Roy NK, Deka A, Bordoloi D, Anip A, Kunnumakkara AB.

Curr Pharm Des. 2016;22(27):4173-200. Review.

PMID:
27291284
41.

The potential role of boswellic acids in cancer prevention and treatment.

Roy NK, Deka A, Bordoloi D, Mishra S, Kumar AP, Sethi G, Kunnumakkara AB.

Cancer Lett. 2016 Jul 10;377(1):74-86. doi: 10.1016/j.canlet.2016.04.017. Epub 2016 Apr 14. Review.

PMID:
27091399
42.

Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer.

Roy NK, Bordoloi D, Monisha J, Padmavathi G, Kotoky J, Golla R, Kunnumakkara AB.

Curr Drug Targets. 2017;18(4):421-435. doi: 10.2174/1389450117666160307145236. Review.

PMID:
26953242
43.

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer.

Monisha J, Roy NK, Bordoloi D, Kumar A, Golla R, Kotoky J, Padmavathi G, Kunnumakkara AB.

Curr Drug Targets. 2017;18(2):232-253. doi: 10.2174/1389450117666160201112330. Review.

PMID:
26844566
44.

Potential of butein, a tetrahydroxychalcone to obliterate cancer.

Padmavathi G, Rathnakaram SR, Monisha J, Bordoloi D, Roy NK, Kunnumakkara AB.

Phytomedicine. 2015 Dec 1;22(13):1163-71. doi: 10.1016/j.phymed.2015.08.015. Epub 2015 Oct 13. Review.

PMID:
26598915
45.

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.

Bordoloi D, Roy NK, Monisha J, Padmavathi G, Kunnumakkara AB.

Recent Pat Anticancer Drug Discov. 2016;11(1):67-97. Review.

PMID:
26537958
46.

Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress.

Thomas D, Govindhan S, Baiju EC, Padmavathi G, Kunnumakkara AB, Padikkala J.

J Basic Clin Physiol Pharmacol. 2015 Sep;26(5):485-90. doi: 10.1515/jbcpp-2014-0093.

PMID:
25915081
47.

ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.

Khwairakpam AD, Shyamananda MS, Sailo BL, Rathnakaram SR, Padmavathi G, Kotoky J, Kunnumakkara AB.

Curr Drug Targets. 2015;16(2):156-63. Review.

PMID:
25537655
48.

Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Quinn BJ, Dallos M, Kitagawa H, Kunnumakkara AB, Memmott RM, Hollander MC, Gills JJ, Dennis PA.

Cancer Prev Res (Phila). 2013 Aug;6(8):801-10. doi: 10.1158/1940-6207.CAPR-13-0058-T. Epub 2013 Jun 14.

49.

Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.

Int J Cancer. 2012 Aug 1;131(3):E292-303. doi: 10.1002/ijc.26442. Epub 2011 Nov 9.

50.

Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors.

Anand P, Sung B, Kunnumakkara AB, Rajasekharan KN, Aggarwal BB.

Biochem Pharmacol. 2011 Dec 15;82(12):1901-9. doi: 10.1016/j.bcp.2011.09.001. Epub 2011 Sep 8. Retraction in: Biochem Pharmacol. 2016 Feb 15;102:144.

Supplemental Content

Loading ...
Support Center